Skip to main content
Promino Nutritional Sciences Inc. logo

Promino Nutritional Sciences Inc. — Investor Relations & Filings

Ticker · MUSL ISIN · CA74290V2049 CSE Manufacturing
Open in API
Filings indexed 217 across all filing types
Latest filing 2023-08-08 Capital/Financing Update
Country CA Canada
Listing CSE MUSL

About Promino Nutritional Sciences Inc.

https://drinkpromino.com/

Promino Nutritional Sciences Inc. is a research-driven nutraceutical company specializing in the development and distribution of science-based, clinically proven nutritional products for muscle health and recovery. The company focuses on patented formulations of essential amino acids (EAAs) designed to optimize muscle protein synthesis (MPS). Its flagship product, Promino™, is a consumer supplement that delivers a precise ratio and potency of all nine EAAs, demonstrated to be significantly more effective than traditional protein sources like whey. Promino's products target athletes and individuals seeking metabolic health improvements. The company also explores clinical applications, such as retaining muscle mass in cancer patients undergoing chemotherapy.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing an update on the launch and distribution of a new product, Rejuvenate™ Muscle Activator, by Element Nutritional Sciences. It contains forward-looking statements about the company's business plans and market expectations. There are no financial statements, regulatory form references, or detailed financial data. The content focuses on business updates and product launch information rather than financial results or regulatory filings. This type of document fits best under the category of Capital/Financing Update (CAP) as it relates to business development and market expansion announcements, which often include updates on product launches and distribution agreements that can impact company valuation and capital market perception. The document length is moderate and contains substantive business update information rather than just an announcement of a report or a regulatory filing. Therefore, the classification is CAP with high confidence.
2023-08-08 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 45-106F1 Report of Exempt Distribution, which is a regulatory filing used in Canadian securities regulation to report distributions of securities under exemptions from prospectus requirements. It includes detailed information about the issuer, distribution dates, purchaser information, types of securities distributed, compensation paid, and other regulatory details. It is not a financial report like an annual or interim report, nor is it a presentation, call transcript, or management report. It is a regulatory compliance filing specific to exempt distributions. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is substantial and contains detailed regulatory information, not just an announcement or certification, so it is not a Report Publication Announcement or Certification. Confidence is high due to the clear form type and content.
2023-07-10 English
News release - English.pdf
Regulatory Filings Classification · 100% confidence The document is a formal submission related to jurisdiction and appointment of an agent for service of process under National Instrument 41-101, which pertains to prospectus requirements for securities distribution. It includes details about the issuer, filing person, agent, and legal jurisdiction for proceedings related to the securities distribution. There are no financial statements, earnings data, management discussion, or other typical financial report content. The document is a regulatory filing related to legal and procedural compliance rather than a financial report or announcement. It is also relatively short (3894 characters) and does not contain or announce a report but rather a legal form submission. Therefore, it fits best under Regulatory Filings (RNS).
2023-06-24 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document announces that Element Nutritional Sciences Inc. has filed its annual financial statements and management's discussion and analysis for the year ended December 31, 2022, as well as interim financial statements for the quarter ended March 31, 2023. It also announces a change to the board with the resignation of a director. The document itself is a news release summarizing these filings and the board change, and it provides links to the full filings on SEDAR. The document length is 4783 characters, which is relatively short and consistent with an announcement rather than the full reports. The text does not contain the actual financial statements or detailed financial data but refers to their filing and availability elsewhere. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the filing of reports and a board change, not the reports themselves.
2023-06-19 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Element Nutritional Sciences has received approval for its product Rejuvenate™ Muscle Activator to be listed in Loblaws stores. It discusses product launch plans, distribution, and forward-looking statements about business prospects. There is no financial data, no regulatory filing references, no meeting or voting information, no audit or management report content, and no mention of any report being attached or published. The content is a corporate announcement about product distribution and business development, which does not fit into any of the specific financial or regulatory filing categories. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories.
2023-06-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the protein quality score of Element Nutritional Sciences' product Rejuvenate™ Muscle Activator. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement focused on product innovation and market positioning, with forward-looking statements typical of a news release. There is no indication that this is an earnings release, annual or interim report, or any regulatory filing. It is not a presentation or call transcript. The content is promotional and informational about a product's scientific measurement and market potential. Therefore, it fits best under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2023-06-12 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.